X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs JUBILANT LIFE SCIENCES - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA JUBILANT LIFE SCIENCES TORRENT PHARMA/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 25.9 20.1 128.7% View Chart
P/BV x 6.3 4.3 148.2% View Chart
Dividend Yield % 3.2 0.4 740.8%  

Financials

 TORRENT PHARMA   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-16
JUBILANT LIFE SCIENCES
Mar-14
TORRENT PHARMA/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,720187 920.8%   
Low Rs1,13465 1,741.2%   
Sales per share (Unadj.) Rs394.5364.3 108.3%  
Earnings per share (Unadj.) Rs101.86.8 1,486.8%  
Cash flow per share (Unadj.) Rs116.324.5 474.8%  
Dividends per share (Unadj.) Rs40.003.00 1,333.3%  
Dividend yield (eoy) %2.82.4 117.7%  
Book value per share (Unadj.) Rs200.3164.9 121.5%  
Shares outstanding (eoy) m169.22159.28 106.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.60.3 1,046.1%   
Avg P/E ratio x14.018.4 76.2%  
P/CF ratio (eoy) x12.35.1 238.6%  
Price / Book Value ratio x7.10.8 932.7%  
Dividend payout %39.343.8 89.7%   
Avg Mkt Cap Rs m241,43520,061 1,203.5%   
No. of employees `00010.96.2 176.1%   
Total wages/salary Rs m8,55911,052 77.4%   
Avg. sales/employee Rs Th6,129.69,383.0 65.3%   
Avg. wages/employee Rs Th785.81,786.9 44.0%   
Avg. net profit/employee Rs Th1,581.3176.3 897.0%   
INCOME DATA
Net Sales Rs m66,76458,034 115.0%  
Other income Rs m2,156191 1,131.4%   
Total revenues Rs m68,92058,224 118.4%   
Gross profit Rs m27,2045,786 470.1%  
Depreciation Rs m2,4612,812 87.5%   
Interest Rs m1,8593,237 57.4%   
Profit before tax Rs m25,041-72 -34,730.7%   
Minority Interest Rs m0-286 0.1%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1,4032,145 -65.4%   
Tax Rs m6,414696 921.0%   
Profit after tax Rs m17,2241,090 1,579.6%  
Gross profit margin %40.710.0 408.7%  
Effective tax rate %25.6-965.9 -2.7%   
Net profit margin %25.81.9 1,373.0%  
BALANCE SHEET DATA
Current assets Rs m46,62229,280 159.2%   
Current liabilities Rs m32,84338,912 84.4%   
Net working cap to sales %20.6-16.6 -124.4%  
Current ratio x1.40.8 188.6%  
Inventory Days Days7484 88.0%  
Debtors Days Days7951 155.9%  
Net fixed assets Rs m39,02955,712 70.1%   
Share capital Rs m846155 547.7%   
"Free" reserves Rs m31,40020,968 149.8%   
Net worth Rs m33,89026,265 129.0%   
Long term debt Rs m18,63717,169 108.6%   
Total assets Rs m90,13688,606 101.7%  
Interest coverage x14.51.0 1,480.2%   
Debt to equity ratio x0.50.7 84.1%  
Sales to assets ratio x0.70.7 113.1%   
Return on assets %21.24.9 433.5%  
Return on equity %50.84.2 1,224.2%  
Return on capital %48.511.6 419.6%  
Exports to sales %43.337.8 114.7%   
Imports to sales %6.916.5 41.6%   
Exports (fob) Rs m28,93421,933 131.9%   
Imports (cif) Rs m4,5849,567 47.9%   
Fx inflow Rs m29,18522,004 132.6%   
Fx outflow Rs m6,02111,749 51.2%   
Net fx Rs m23,16510,255 225.9%   
CASH FLOW
From Operations Rs m27,1328,026 338.1%  
From Investments Rs m-7,014-1,744 402.1%  
From Financial Activity Rs m-14,352-4,447 322.7%  
Net Cashflow Rs m5,7671,834 314.3%  

Share Holding

Indian Promoters % 71.5 45.6 156.8%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 7.0 8.7 80.7%  
FIIs % 12.6 21.2 59.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 21.1 41.7%  
Shareholders   26,511 23,815 111.3%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   ALEMBIC PHARMA  STRIDES SHASUN LTD  FDC LTD.  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare TORRENT PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Remain Volatile Ahead of US Growth Concerns(RoundUp)

Benchmark indices in US corrected marginally by 0.8% during the week. Minutes of Federal Reserve's July meeting are out and the situation looks to be in favor of the emerging markets.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Aug 18, 2017 (Close)

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS